Columbia University, U.S.
ARF-BP1 identified as potential therapeutic target against cancer
Published in Cancer Law Weekly, August 12th, 2006
"In this review, we discuss the recent identification of ARF-BPI (also known as Mule, UREBI, E3 (histone), LASUI, and HectH9). ARF-BPI, a HECT domain-containing E3 ubiquitin ligase, interacts with ARF and p53," researchers in the United States reported.
"Its ubiquitin ligase activity is inhibited by ARF. Inactivation of ARF-BPI stabilised p53 and induced apoptosis. Notably, inactivation of ARF-BPI also caused cell growth repression in p53-null cells and breast cancer cells with mutant p53," explained D. Chen and colleagues, Columbia University.
The...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Cancer Law Weekly
Source: Cancer Law Weekly (2006-08-12)
More Articles from Cancer Law Weekly
- Cell Press
Abnormal stimulation of a cellular trigger causes tumor-like growths in mice - Charing Cross Hospital, London, U.K.
A mutation is associated with mild clinical features in spindle cell melanoma - DUSA Pharmaceuticals
DUSA Pharmaceuticals sues additional physicians and a chemical supplier for patent infringement - G. Gaslini Children's Hospital, Genoa, Italy
Helicobacter pylori cause of gastrointestinal disease in children with hemato-oncologic disease - LQ
Market for counterfeit drugs continues increasing - Mayo Clinic, U.S.
A variety of liver cancer activities are blocked by sulfatase 1 enzyme - More from this issue of Cancer Law Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
